1-3 of 3
Samedy Ouk
Close
Sort by
Journal Articles

Targeted Nanotherapy of Hematologic Malignancies Using Gold Nanoframework-Based Delivery of a Novel NF-Kb Inhibitor

Manpreet Bariana, Beilu Zhang, Jingyu Sun, Elena Cassella, Janice Rateshwar, Ming Tony Tan, Weiwei Wang, Jinping Wang, Rena Feinman, David Siegel, Hsiou-Chi Liou, Samedy Ouk, Patrizia Mondello, Hongjun Wang, Johannes Zakrzewski
Journal: Blood
Blood (2022) 140 (Supplement 1): 6018–6019.
https://doi.org/10.1182/blood-2022-160324
Published: 2022
Journal Articles

Targeting Cellular Metabolism and Survival in Chronic Lymphocytic Leukemia and Richter Syndrome Cells By a Novel NF-Kb Inhibitor

Tiziana Vaisitti, PhD, Federica Gaudino, Samedy Ouk, Sara Serra, PhD, Johannes L. Zakrzewski, MD, Erica B. Bhavsar, John N. Allan, MD, Hsiou-Chi Liou, PhD, Richard R. Furman, Silvia Deaglio, MD PhD
Journal: Blood
Blood (2016) 128 (22): 304.
https://doi.org/10.1182/blood.V128.22.304.304
Published: 2016
Journal Articles

Targeted Therapy of B Cell Lymphoma with a Direct Inhibitor of the NF-κB Subunit c-Rel

Yusuke Shono, MD PhD, Andrea Z. Tuckett, PhD, Hsiou-Chi Liou, PhD, Samedy Ouk, PhD, Ekaterina Doubrovina, MD PhD, Mikhail Doubrovin, MD PhD, Enrico Derenzini, MD, Mary I. Scallion, BS, Jennifer J. Tsai, MD, Odette M. Smith, Anas Younes, MD PhD, Richard J. O'Reilly, MD PhD, Marcel R.M. van den Brink, MD PhD, Johannes L. Zakrzewski, MD
Journal: Blood
Blood (2014) 124 (21): 507.
https://doi.org/10.1182/blood.V124.21.507.507
Published: 2014